Avanir Pharmaceuticals Inc
US ˙ NASDAQ
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAVNR / Avanir Pharmaceuticals Inc
InstitutionUbs Ag
Latest Disclosed Ownership174,874 shares
Latest Disclosed Value $ 2,084,000
Ubs Ag ownership in AVNR / Avanir Pharmaceuticals Inc

On November 12, 2014 - Ubs Ag filed a 13F-HR form disclosing ownership of 174,874 shares of Avanir Pharmaceuticals Inc (US:AVNR) valued at $2,084,000 USD as of September 30, 2014. The entity filed a previous 13F-HR on August 14, 2014 disclosing 95,354 shares of Avanir Pharmaceuticals Inc. This represents a change in shares of 83.39% during the quarter.

Ubs Ag has a history of taking positions in derivatives of the underlying security (AVNR) in the form of stock options. The firm currently holds call options representing 22,600 of underlying shares valued at $269,000 USD and put options representing 20,100 of underlying shares valued at $240,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AVNR / Avanir Pharmaceuticals Inc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2014-11-12 2014-09-30 13F AVANIR PHARMACEUTICALS CL A NEW 05348P401 174,874 79,520 83.39 2,084 288.08 0.0015
2014-08-14 2014-06-30 13F AVANIR PHARMACEUTICALS CL A NEW 05348P401 95,354 50,904 114.52 537 229.45 0.0004
2014-05-16 2014-03-31 13F/A-1 AVANIR PHARMACEUTICALS CL A NEW 05348P401 44,450 -1,324 -2.89 163 5.84 0.0001
2014-05-15 2014-03-31 13F AVANIR PHARMACEUTICALS CL A NEW 05348P401 44,450 163
2014-05-21 2013-12-31 13F/A-1 AVANIR PHARMACEUTICALS CL A NEW 05348P401 45,774 -171,968 -78.98 154 -83.28 0.0001
2014-02-14 2013-12-31 13F AVANIR PHARMACEUTICALS CL A NEW 05348P401 45,774 154
2013-11-13 2013-09-30 13F AVANIR PHARMACEUTICALS CL A NEW 05348P401 217,742 90,372 70.95 921 57.17 0.0009
2013-08-14 2013-06-30 13F AVANIR PHARMACEUTICALS CL A NEW 05348P401 127,370 127,370 586 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F AVANIR PHARMACEUTICALS CL A NEW Call 22,600 -65.50 269 -27.10 n/a n/a n/a
2014-08-14 2014-06-30 13F AVANIR PHARMACEUTICALS CL A NEW Call 65,500 -45.46 369 -16.33 n/a n/a n/a
2014-05-16 2014-03-31 13F/A AVANIR PHARMACEUTICALS CL A NEW Call 120,100 -4.46 441 4.50 n/a n/a n/a
2014-05-15 2014-03-31 13F AVANIR PHARMACEUTICALS CL A NEW Call 120,100 441 n/a n/a n/a
2014-05-21 2013-12-31 13F/A AVANIR PHARMACEUTICALS CL A NEW Call 125,700 250.14 422 177.63 n/a n/a n/a
2014-02-14 2013-12-31 13F AVANIR PHARMACEUTICALS CL A NEW Call 125,700 422 n/a n/a n/a
2013-11-13 2013-09-30 13F AVANIR PHARMACEUTICALS CL A NEW Call 35,900 -22.46 152 -28.64 n/a n/a n/a
2013-08-14 2013-06-30 13F AVANIR PHARMACEUTICALS CL A NEW Call 46,300 213 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F AVANIR PHARMACEUTICALS CL A NEW Put 20,100 20,000.00 240 23,900.00 n/a n/a n/a
2014-08-14 2014-06-30 13F AVANIR PHARMACEUTICALS CL A NEW Put 100 -98.85 1 -96.87 n/a n/a n/a
2014-05-16 2014-03-31 13F/A AVANIR PHARMACEUTICALS CL A NEW Put 8,700 -47.59 32 -42.86 n/a n/a n/a
2014-05-15 2014-03-31 13F AVANIR PHARMACEUTICALS CL A NEW Put 8,700 32 n/a n/a n/a
2014-05-21 2013-12-31 13F/A AVANIR PHARMACEUTICALS CL A NEW Put 16,600 8,200.00 56 5,500.00 n/a n/a n/a
2014-02-14 2013-12-31 13F AVANIR PHARMACEUTICALS CL A NEW Put 16,600 56 n/a n/a n/a
2013-11-13 2013-09-30 13F AVANIR PHARMACEUTICALS CL A NEW Put 200 -90.48 1 -90.00 n/a n/a n/a
2013-08-14 2013-06-30 13F AVANIR PHARMACEUTICALS CL A NEW Put 2,100 10 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.